| Primary |
| Hypertension |
82.8% |
| Blood Pressure Increased |
2.9% |
| Tachycardia |
2.2% |
| Atrial Fibrillation |
1.2% |
| Blood Cholesterol Increased |
1.1% |
| Blood Pressure |
1.1% |
| Arrhythmia |
1.0% |
| Heart Rate Increased |
1.0% |
| Depression |
0.8% |
| Hypothyroidism |
0.8% |
| Coronary Artery Disease |
0.6% |
| Diabetes Mellitus |
0.6% |
| Palpitations |
0.6% |
| Atrial Flutter |
0.5% |
| Convulsion |
0.5% |
| Type 2 Diabetes Mellitus |
0.5% |
| Angina Pectoris |
0.4% |
| Cardiac Disorder |
0.4% |
| Cardiac Failure Congestive |
0.4% |
| Erectile Dysfunction |
0.4% |
|
| Heart Rate Decreased |
8.8% |
| Oedema Peripheral |
8.3% |
| Rash |
8.3% |
| Bradycardia |
7.7% |
| Fatigue |
7.2% |
| Headache |
5.7% |
| Weight Increased |
5.7% |
| Dyspnoea |
5.0% |
| Insomnia |
5.0% |
| Pain In Extremity |
4.8% |
| Vision Blurred |
4.2% |
| Alopecia |
3.5% |
| Blood Pressure Increased |
3.5% |
| Diarrhoea |
3.3% |
| Drug Ineffective |
3.3% |
| Nausea |
3.3% |
| Vomiting |
3.3% |
| Dizziness |
3.1% |
| Hypotension |
3.1% |
| Palpitations |
3.1% |
|
| Secondary |
| Hypertension |
37.7% |
| Product Used For Unknown Indication |
37.7% |
| Arrhythmia |
2.7% |
| Convulsion |
2.6% |
| Migraine |
1.8% |
| Prostate Cancer |
1.7% |
| Atrial Fibrillation |
1.6% |
| Drug Use For Unknown Indication |
1.5% |
| Blood Pressure |
1.3% |
| Depression |
1.3% |
| Anaesthesia |
1.2% |
| Off Label Use |
1.2% |
| Blood Pressure Abnormal |
1.1% |
| Heart Rate Increased |
1.1% |
| Atrial Flutter |
1.0% |
| Pain |
1.0% |
| Blood Pressure Increased |
0.9% |
| Lung Neoplasm Malignant |
0.9% |
| Hypothyroidism |
0.8% |
| Cardiac Disorder |
0.7% |
|
| Weight Increased |
7.9% |
| Headache |
7.0% |
| Blood Pressure Increased |
6.1% |
| Weight Decreased |
6.1% |
| Heart Rate Decreased |
5.3% |
| Hypotension |
5.3% |
| Muscular Weakness |
5.3% |
| Pain In Extremity |
5.3% |
| Rash |
5.3% |
| Syncope |
5.3% |
| Vomiting |
5.3% |
| Asthenia |
4.4% |
| Atrial Fibrillation |
4.4% |
| Drug Hypersensitivity |
4.4% |
| Drug Intolerance |
4.4% |
| Vision Blurred |
4.4% |
| Dyspnoea |
3.5% |
| Loss Of Consciousness |
3.5% |
| Malaise |
3.5% |
| Pneumonia |
3.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
41.0% |
| Hypertension |
15.8% |
| Drug Use For Unknown Indication |
6.2% |
| Blood Cholesterol Increased |
5.1% |
| Atrial Fibrillation |
3.2% |
| Rheumatoid Arthritis |
3.0% |
| Cardiac Disorder |
2.9% |
| Pain |
2.8% |
| Blood Pressure |
2.7% |
| Diabetes Mellitus |
2.4% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Depression |
1.8% |
| Anxiety |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Asthma |
1.5% |
| Prophylaxis |
1.5% |
| Type 2 Diabetes Mellitus |
1.4% |
| High Density Lipoprotein Decreased |
1.2% |
| Crohn's Disease |
1.1% |
| Osteoporosis |
1.0% |
|
| Flushing |
12.1% |
| Pruritus |
8.0% |
| Vomiting |
6.3% |
| Drug Ineffective |
5.8% |
| Nausea |
5.8% |
| Pain |
5.6% |
| Dyspnoea |
4.9% |
| Weight Decreased |
4.9% |
| Diarrhoea |
4.4% |
| Weight Increased |
4.4% |
| Headache |
4.2% |
| Myalgia |
4.2% |
| Rash |
4.2% |
| Pain In Extremity |
3.8% |
| Skin Burning Sensation |
3.8% |
| Paraesthesia |
3.7% |
| Injection Site Pain |
3.5% |
| Vision Blurred |
3.5% |
| Wrong Technique In Drug Usage Process |
3.5% |
| Fatigue |
3.2% |
|
| Interacting |
| Depression |
24.7% |
| Hypertension |
15.1% |
| Extrasystoles |
12.3% |
| Hypothyroidism |
12.3% |
| Migraine |
12.3% |
| Gastrooesophageal Reflux Disease |
6.8% |
| Product Used For Unknown Indication |
5.5% |
| Erectile Dysfunction |
4.1% |
| Benign Prostatic Hyperplasia |
2.7% |
| Abdominal Discomfort |
1.4% |
| Antasthmatic Drug Level |
1.4% |
| Blood Pressure |
1.4% |
|
| Tremor |
29.4% |
| Extrasystoles |
23.5% |
| Drug Effect Decreased |
11.8% |
| Sciatica |
11.8% |
| Drug Interaction |
5.9% |
| Emotional Distress |
5.9% |
| Feeling Abnormal |
5.9% |
| Speech Disorder |
5.9% |
|
